EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings

Justine Sunshine, Michael Shaffer, Linda L Han, Deepali Gaikwad, Amelia A Houana iD, Maria Tarcela Gler, Sri Rezeki Hadinegoro, Willem A Hanekom, Javier R Lama iD, Monde Muyoyeta iD, Sissy Musala, Videlis Nduba iD und 12 weitere

Open Forum Infectious Diseases · 01.07.2026 · 13 (7)

DOI: 10.1093/ofid/ofag437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 24.07.2026. Verfasst von Justine Sunshine und 23 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Development, Gates Medical Research Institute, Cambridge, Massachusetts, USA. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Predictive biomarkers for symptomatic tuberculosis (TB) progression would transform targeted prevention efforts. Although interferon-gamma release assays (IGRAs), including QuantiFERON® TB-Gold Plus (QFT-Plus), have been studied for this purpose, systematic evaluation of the QFT-Plus TB1 and TB2 Interferon-Gamma (IFNγ) concentrations remains limited, particularly in high-burden TB settings.

Methods

Baseline TB1 and TB2 IFNγ concentrations from 5246 participants (ages 15–34 years) in TB-endemic regions were analyzed in relation to subsequent TB outcomes over a median of 525 days follow-up (NCT05190146). Participants were categorized as controls (no TB), suspected TB (no microbiological confirmation), or laboratory-confirmed TB, including a subset meeting a stringent case definition (≥2 positive microbiologic tests). Associations between baseline IFNγ concentrations and progression to symptomatic TB were assessed.

Results

In the full cohort (IGRA+/− participants), baseline TB2 IFNγ concentrations were significantly higher compared with controls among participants who developed suspected TB (P = .01), laboratory-confirmed TB (P = .01), or met the stringent case definition (P < .0001). In IGRA+ participants, baseline TB2 concentrations were significantly higher than controls in suspected (P = .01) and laboratory-confirmed (P = .02) groups. Associations with baseline TB1 IFNγ concentrations and TB progression were observed for participants meeting the stringent case definition within the full cohort (P = .001). Among stringent definition cases, TB2 concentrations achieved an area under the receiver operating characteristic curve of 0.84, with sensitivity of 80% and specificity of 78%.

Conclusions

Quantitative IFNγ concentrations from QFT-Plus, particularly TB2, were associated with progression to symptomatic TB, met or exceeded WHO-recommended sensitivity and specificity thresholds for predictive biomarkers, and may support biomarker-based stratification in TB clinical research.

Schlagwörter

Stichwörter der Autor:innen

IFNγIGRAQFT-plusbiomarkertuberculosis

Autor:innen und Institutionen

  • Clinical Development, Gates Medical Research Institute, Cambridge, Massachusetts, USA.
  • Department of Pulmonary Medicine, PCMC'S PGI YCM Hospital, Pune, Maharashtra, India.
  • Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique.
  • TB HIV Innovations and Clinical Research Foundation, Cavite, Philippines.
  • Department of Child Health Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
  • Africa Health Research Institute, KwaZulu-Natal, South Africa.

ORCID-Profile: Amelia A Houana, Javier R Lama, Monde Muyoyeta, Videlis Nduba, Jayne S Sutherland, Celso Khosa, Alexander C Schmidt

Zitieren

APA

Sunshine, J., Shaffer, M., Han, L. L., Gaikwad, D., Houana, A. A., Gler, M. T., Hadinegoro, S. R., Hanekom, W. A., Lama, J. R., Muyoyeta, M., Musala, S., Nduba, V., Rolla, V. C., Roy, T., Sutherland, J. S., Khosa, C., Wajja, A., Walker, T. M., Cinar, A., …, & for TBV02-E01 Study Group (2026). Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings. Open Forum Infectious Diseases, 13(7). https://doi.org/10.1093/ofid/ofag437

Vancouver

Sunshine J, Shaffer M, Han LL, Gaikwad D, Houana AA, Gler MT, et al. Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings. Open Forum Infectious Diseases. 2026;13(7). doi:10.1093/ofid/ofag437

BibTeX
@article{Sunshine2026,
  author = {Sunshine, Justine and Shaffer, Michael and Han, Linda L and Gaikwad, Deepali and Houana, Amelia A and Gler, Maria Tarcela and Hadinegoro, Sri Rezeki and Hanekom, Willem A and Lama, Javier R and Muyoyeta, Monde and Musala, Sissy and Nduba, Videlis and Rolla, Valeria C and Roy, Tapash and Sutherland, Jayne S and Khosa, Celso and Wajja, Anne and Walker, Timothy M and Cinar, Amy and Schmidt, Alexander C and Dagnew, Alemnew F and Frahm, Nicole and for TBV02-E01 Study Group, for TBV02-E01 Study Group and for TBV02-E01 Study Group, for TBV02-E01 Study Group},
  title = {Associations Between QuantiFERON-TB Gold Plus IFNγ Concentrations and Progression to Symptomatic Tuberculosis in Global High-Burden TB Settings},
  journal = {Open Forum Infectious Diseases},
  year = {2026},
  volume = {13},
  number = {7},
  doi = {10.1093/ofid/ofag437}
}
Kostenlos starten →